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A series of 1-aryl-3,4-dihydroisoquinolines (DHIQs) were synthesized and their barriers to bond 
rotation were determined by means of VT-NMR, dynamic HPLC or racemization studies. 
Although they all presented lower rotational stability than the related 1-arylisoquinolines (such 
as QUINAP), certain 1-aryl-DHIQ structures had a sufficiently high barrier to bond rotation to 
show axial chirality. These compounds included 1-(2-triflyl-1-naphthyl)-4,5-
dihydroisoquinoline 4h and 1-(2-diphenylphosphanyl-1-naphthyl)-4,5-dihydroisoquinoline 4i. 
This discovery opens the door to the development of a new group of axially chiral N,P ligands 
for asymmetric synthesis and also potentially to new strategies for the synthesis of axially chiral 
1-arylisoquinolines. 
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1. Introduction 
The majority of axially chiral compounds are biaryls, whether 
biphenyls or binaphthyls1 or their heterocyclic counterparts.2 
Particularly valuable are biaryls containing the isoquinoline ring,3 
which function as atropisomeric chiral ligands because their basic 
nitrogen atom allows bidentate coordination in P,N ligands4 such 
as QUINAP (Figure 1).  QUINAP is the ligand of choice in many 
asymmetric reactions,5 including asymmetric hydroborations, 
diborations, dipolar cycloadditions, conjugate additions and 
additions to iminium ions. 
Configurational stability about the biaryl axis in 1-
naphthylisoquinolines depends on the substituent at the 2-
position of the naphthyl ring.  The 2-unsubstituted structure 1a is 
configurationally unstable at room temperature, with an 
estimated half-life for racemization of 13 min at –20 °C.6 In 
contrast, the amino-substituted structure 1b is configurationally 
stable, with a barrier to bond rotation of 125.4 kJ mol–1.7 The 
more substituted compounds 1c8 and QUINAP 1d5 showed no 
sign of racemization on extended heating. 
One report of a related partially saturated structure,9 3,4-
dihydroisoquinoline 2a, suggests that its barrier to rotation is too 
low to permit resolution, but the rate of bond rotation was not 
quantified. A chiral derivative 2b nonetheless displayed 
separable diastereoisomeric atropisomers, but again no barrier 
was reported. The diastereoisomers of the corresponding triflate 
2c were not separable. Related 1-aryl-3,4-dihydroisoquinolines 
are of medicinal interest as potent neuroprotectors.10 
 
Figure 1. Bond rotations in 1-naphthylisoquinolines and their 
3,4-dihydroisoquinoline analogues. 
Although 1-aryl-DHIQs are more conformationally flexible 
than the related fully aromatic isoquinolines, and evidently 
display lower barriers to rotation, they do show potential for 
atropisomerism and could provide a new class of axially chiral 
compounds with potential applications as ligands or building 
blocks for asymmetric synthesis or chiral ligands. QUINAP is 
typically produced in enantiomerically pure form by classical 
resolution.4,5,11  Methods have also been reported for its 
asymmetric synthesis by dynamic resolution techniques, relying 
of the control of the kinetics and thermodynamics of bond 
rotation.12 Further interest arises from the possibility of using 
redox interconversions between QUINAP and its partially 
saturated analogues to control dynamic resolution processes. In 
this paper we describe our investigation into the control of 
rotational barriers in 1-aryl-3,4-dihydroisoquinolines as a 
potential new class of non-biaryl atropisomers.13 
2. Results and discussion 
2.1. Starting materials 
A range of racemic 1-aryl-DHIQs halogenated at the 2-
position of the 1-aryl ring (4a-g) were readily synthesized in high 
yields from the corresponding amides 3a-g by the modified 
Bischler-Napieralski cyclisation reported by Movassaghi et al.14 
Amide starting materials for the cyclisation were made either by 
acylation of phenethylamine with available 2-halobenzoyl 
chloride or 1-naphthoyl chloride (giving 3a-d). The remaining 
amides 3e-f were made by halogenation of 3d by means of 
rhodium15 or palladium16 catalyzed C-H activation reactions, with 
the amide as a directing group for chemoselective halogenation at 
the ortho position of the 1-naphthyl ring.  
 
Scheme 1. Synthesis of 1-acyl-3,4-dihydroisoquinolines.  
Reagents: (a) NCS, Pd(OAc)2 (5 mol%), TfOH, Na2S2O8, DCE, 80 
°C, 32 h; (b) NBS/NIS, [RhCp*Cl2]2 (2.5 mol%), AgSbF6 (10 
mol%), PivOH, DCE, 70 °C, 18 h.  
In addition, triflyl-substituted DHIQ 4h was made by the 
method of Li et al.9 (Scheme 2) and converted into phosphine 
oxide 4i by palladium-catalyzed coupling17 with Ph2P(O)H. 
 
Scheme 2. Synthesis of substituted 1-naphthyl-3,4-
dihydroisoquinolines.  
2.2. Determination of the barriers to bond rotation in variously 
substituted DHIQs 
Variable temperature NMR (VT-NMR) studies were carried 
out to estimate the rate of bond rotation about the Ar-DHIQ axis 
of the less hindered group of compounds 4a-d. The 1H NMR line 
shapes of the signals arising from the potentially diatereotopic 
protons in the –CH2–CH2– unit of the DHIQ were monitored in 
CDCl3 at temperatures between –30 °C and +30 °C. The line 
shapes were modelled using the commercial program gNMR.18,19 
Table 1 illustrates (for one example, bromo-substituted 4b) the 
modelled and observed line shapes of the two diastereotopic 
methylene protons (HA, HB)  to the nitrogen atom at a series of 
temperatures, and shows the estimated rate constant, k, for their 
exchange. 
N
NH2
DG‡ = 125.4 kJ mol–1
at 25 ˚ C
N
DG‡ = 77.5 kJ mol–1
at –20 ˚ C 
(non-atropisomeric)
1a 1b
N
PPh2
Resolvable
Ph
N
PPh2
Rotationally unstable
at 25 ˚ C
2a 2b
N
No racemisation
after
24 h at 80 ˚C
N
PPh2
No racemisation
after 
24 h at 65 ˚C
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OH
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N
OTf
Diastereoisomers
interconvert
Ph
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1-Naphthylisoquinolines
1-Naphthyl-3,4-dihydroisoquinolines
Et3N,
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3a X = Cl; 5-H, 6-H 99% 
3b X = Br; 5-H, 6-H 91%
3c X = I; 5-H, 6-H 99%
3d X = H; 5,6-benzo 99%
3e X = Cl; 5,6-benzo 55%
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3g X = I; 5,6-benzo 34%
HN
O XO X
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Tf2O, 2-ClPyr
CH2Cl2, 45 °C, 
16 h
N
X
4a X = Cl; 5-H, 6-H 98% 
4b X = Br; 5-H, 6-H 70%
4c X = I; 5-H, 6-H 83%
4d X = H; 5,6-benzo 80%
4e X = Cl; 5,6-benzo 88% 
4f X = Br; 5,6-benzo 90%
4g X = I; 5,6-benzo 65%
ab
NH2
N
OH
+
3 steps
85% overall
method of
Li et al.9
N
OTf
Ph2P(O)H, DIPEA
Pd(OAc)2 (10 mol%)
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Table 1. Line shape analysis in the VT NMR study of 4b 
T / 
ºC 
Experimental line shape Modelled line shape 
k / s–
1 
-
30 
 
 
 
 
 
 
1 
-
10 
  
20 
0 
  
57 
20 
  
220 
30 
 
 
 
550 
 
These rates were analysed using the Eyring equation, allowing 
calculation of the barrier to bond rotation (∆G‡) and an estimation 
the half life for racemization (t½rac) of 4a-d in solution at a given 
temperature.  
It was not possible to use VT-NMR to derive a barrier to 
rotation of the more sterically encumbered substrate 4e since no 
line broadening or coalescences were observed even at 120 ºC in 
1,2-dichlorobenzene-d4. Rotationally restricted compounds with 
half lives for racemization falling into the timescale of minutes at 
ambient temperature are typically difficult to analyse by VT-
NMR for this reason, but this racemization profile is ideal for 
investigation by dynamic (variable temperature) HPLC (DHPLC) 
on a chiral stationary phase.13a,19-21 
DHPLC studies were undertaken using DHIQs 4e-g. For 4e, 
all the chiral stationary phases and eluents we explored showed a 
single peak, even on cooling the column to 0 ºC. Although no 
numerical values for the barrier to rotation of 4e were obtained, 
we assume therefore that chloro-substituted 4e rotates freely (that 
is, on a time scale of seconds or less) at room temperature. 
More information was obtained from 4f, which showed peak 
shapes characteristic of racemisation on the timescale of elution 
on a (R,R)-Whelk-O1 stationary phase, eluting with n-
hexane/isopropanol (60:40).  Peak profiles were monitored at 20, 
30 and 40 °C (Table 2) and the parameters obtained from the 
profiles were entered into the Unified Equation for Dynamic 
Chromatography.19,20 From this equation, the rates of 
interconversion of the two enantiomers of 4f were calculated. 
An Eyring plot of this data revelaed that 4f was almost 
atropisomeric22 at 25 ºC (∆G‡298 = 92.6 kJ mol–1; t½rac = 900 s). 
Table 2. Dynamic HPLC profiles for 4f on the (R,R)-Whelk-O1 
chiral stationary phase, eluting with n-hexane/isopropanol (60:40). 
T 
/ ºC 
Observed peak shape 
k 
/ 103 s-1 
20 
 
4.5  
30 
 
7.1  
40 
 
 
9.9  
 
Similar approximate analysis of the DHPLC trace of 4g 
around 0 °C indicated that 4g had a lower barrier to rotation than 
4f.  The replacement of a bromine atom by a bulkier iodine atom 
at the naphthyl ring's ortho position did not increase rotational 
stability at the Ar-DHIQ bond. Presumably the bigger atomic 
radius of iodine is countered by the longer bond length of C–I (a 
similar effect is well established in A values).23 
Table 3. Summary of kinetic parameters for bond rotations in 1-
arylDHIQs 
 
Cpd. X = ∆H‡ 
/ kJ mol–1 
∆S‡ 
/ J mol–1 K–1 
∆G‡298 
/ kJ mol–1 
t1/2
rac
298
a 
4a Cl 56.6 –9 59.2 ≈ 10-3 s 
4b Br 50.7 –26 58.4 < 10-3  s 
4c I 64.0 +20 57.9 < 10-3  s 
4d H 55.1 +1 54.7 ≈ 10-4 s 
4e Cl – – < 90b < 5 min 
4f Br 34.6 –195 92.6 15 min 
4g I – – 
81.9c 
< 1 mind 
4h OTf 10.7 +14.5 103.1 36 days 
4i P(O)Ph2 – – >>100 >25 days 
 
N
X
4a-4c
N
X
4d-4i
 4 
aEstimated half life for racemization.  bNot determined (achiral 
by HPLC). cDetermined at 0 °C.  Insufficient data to allow 
calculation of ∆H‡ and ∆S‡.  dAssuming ∆S‡ = 0. 
In marked contrast, compound 4h bearing an O-triflyl group at 
the ortho position of the naphthyl core showed no signs of 
racemization on the timescale of elution from a chiral stationary 
phase at room temperature. The enantiomers of 4h were therefore 
separated on a small scale by semi-preparative HPLC, and their 
interconversion was studied in isopropanol at three different 
temperatures: 43, 50 and 58 °C. The decrease in ee over time was 
monitored and plots of ln(ee) against time gave for the rate of 
racemisation at each temperature. Using the Eyring equation, 
values of ΔG‡ at room temperature could be derived along with 
ΔS‡ and ΔH‡ (Table 3).  From these values we estimate 4h to 
have a half life for racemization of at least one month in solution. 
We envisaged that a phosphine oxide substituent at the 
naphthyl 2-position might further increase the barrier to rotation, 
and possibly provide a valuable contrast to dihydro-QUINAP 
(2a, Figure 1), which was reported to be rotationally unstable at 
room temperature. Indeed, chiral HPLC traces of rac-4i showed 
no racemisation on-column at 50 ºC, suggesting a half life for 
racemization at this temperature of at least 30 min, and hence a 
barrier to bond rotation of >>100 kJ mol–1. Phosphine oxide 4i is 
thus the first reported rotationally stable 1-aryl-3,4-
dihydroisoquinoline. Interestingly, tertiary phosphine oxide N,P-
ligands have been found to display higher catalytic activities in, 
for example, olefin hydroformylation reactions than their tertiary 
phosphine analogues,23 suggesting the possible use of 4i itself as 
a chiral ligand. 
3. Conclusion 
A series of rotationally restricted and axially chiral 1-aryl-3,4-
dihydroisoquinolines (1-aryl-DHIQ) were readily synthesized 
using inter or intramolecular electrophilic aromatic substitution 
chemistry. Their barriers to rotation about their Ar–CN bond 
were determined by means of VT-NMR, dynamic HPLC and 
racemization studies. Despite significantly greater molecular 
flexibility than the related 1-aryl-isoquinolines, two 1-naphthyl 
DHIQs showed stable axial chirality at ambient temperature. 
Notably, triflate, as a pseudohalide, provided a much greater 
barrier to bond rotation than the equivalent halides (Br, I). This 
first report of atropisomeric 1-aryl-3,4-dihydroisoquinolines 
opens the door to the development of new axially chiral 3,4-
dihydroisoquinoline-containing N,P ligands for asymmetric 
synthesis. 
4. Experimental 
4.1. General procedure for amide (3a-d) formation from 2-
phenylethylamine and an acyl chloride. 
2-Phenylethylamine (1 equiv) and Et3N (2 equiv) were added 
to a solution of the acyl chloride (1 equiv) in dichloromethane 
and the reaction mixture was stirred for 16 h at room 
temperature. The solvent and the excess Et3N were removed 
under reduced pressure. The residue was suspended in water and 
extracted twice in EtOAc. The combined organic layer was 
washed with brine and dried over MgSO4, filtered and 
concentrated under reduced pressure. The crude product was used 
without any further purification. The experimental data for 2-
chloro-N-phenethylbenzamide 3a,25a 2-bromo-N-
phenethylbenzamide 3b,25b 2-iodo-N-phenethylbenzamide 3c25c 
and N-phenethyl-1-naphthamide 3d25d were consistent with the 
literature. 
4.1.1. 2-Chloro-N-phenethyl-1-naphthamide (3e) 
Compound 3e was prepared according to the method of Rao et 
al.16 N-Phenethyl-1-naphthamide 3d (100 mg, 0.36 mmol), NCS 
(64 mg, 0.48 mmol), Pd(OAc)2 (6 mg, 0.018 mmol, 5 mol%) and 
sodium persulfate (174 mg, 0.72 mmol) were dissolved in dry 
1,2-DCE (2 mL) in a flame-dried sealed vial under argon. The 
mixture was degassed under reduced pressure and the vessel 
filled with argon. TfOH (110 mg, 0.72 mmol) was added 
dropwise. The reaction mixture was stirred for 32 h at 80 ºC. 
After cooling to room temperature, the reaction was quenched by 
adding saturated aqueous NaHCO3. The reaction mixture was 
diluted with dichloromethane. The organic layer was dried over 
MgSO4, filtered, concentrated under reduced pressure and the 
crude product was purified by flash column chromatography 
(80:20 Pet. Ether:EtOAc) to afford the title compound as a 
yellow oil (62 mg, 55%); 3e: Rf (70:30 Pet. Ether:EtOAc) 0.45; 
IR (film, cm-1): νmax = 3268, 1636 (C=O), 821; 1H NMR (400 
MHz, CDCl3): δH = 7.90 (1 H, dd, J=6.2, 3.4 Hz, ArH), 7.80 (1 
H, dd, J=8.2, 0.9 Hz, ArH), 7.63 (1 H, dd, J=7.6, 1.3 Hz, ArH), 
7.51 - 7.47 (2 H, m, 2xArH), 7.45 - 7.42 (1 H, m, ArH), 7.34 - 
7.29 (3 H, m, 3xArH), 7.23 (2 H, m, 2xArH), 5.81 (1 H, br. s., 
NH), 3.84 (2 H, dt, J=7.1, 6.3 Hz, NHCH2CH2Ph), 3.01 ppm (2 
H, t, J=7.1 Hz, NHCH2CH2Ph); 
13C {1H} NMR (100 MHz, 
CDCl3): δC = 171.0 (C=O), 138.8 (ArC), 135.4 (ArC), 134.3 
(ArC), 130.4 (ArC), 130.2 (ArC), 130.1 (ArC), 129.0 (2xArC),  
128.7 (ArC), 128.6 (ArC), 127.9 (ArC), 127.7 (ArC), 126.9 
(ArC), 126.5 (ArC), 126.2 (ArC), 125.5 (ArC), 41.2 
(NHCH2CH2Ph), 35.2 (NHCH2CH2Ph) ppm; HRMS (ESI+) m/z 
calcd for C19H16ClNONa [M+Na
+]: 332.0813, found: 332.0820. 
4.1.2. 2-Bromo-N-phenethyl-1-naphthamide (3f) 
Compound 3f was prepared according to the method of 
Glorius et al.15 [RhCp*Cl2]2 (0.058 g, 0.09 mmol, 2.5 mol%), 
AgSbF6 (0.127 g, 0.36 mmol, 10 mol%) and PivOH (0.5 ml, 4.00 
mmol). 1,2-DCE (18 mL), N-phenethyl-1-naphthamide 3d (1.000 
g, 3.63 mmol) and NBS (0.970 g, 5.45 mmol) were added under 
nitrogen to a flame-dried round-bottom flask. The reaction 
mixture was degassed under reduced pressure, the vessel filled 
with nitrogen, and the mixture heated at 65 ºC for 18 h. The 
mixture was cooled to room temperature, diluted with EtOAc and 
filtered through a short pad of silica gel and eluted with EtOAc. 
After removal of solvent under reduced pressure, the crude 
product was purified by flash column chromatography (70:30 
Pet. Ether:EtOAc) to afford the title compound as a white solid 
(1.184 g, 92%); 3f: Rf (50:50 Pet. Ether:EtOAc) 0.5; m.p. 135-
137 ºC;  IR (film, cm-1): νmax = 3264, 1639 (C=O), 1530, 760; 1H 
NMR (400 MHz, CDCl3): δH = 7.93 - 7.81 (3 H, m, 3xArH), 7.52 
(1 H, dd, J = 7.1, 1.5 Hz, ArH), 7.50 - 7.42 (1 H, m, ArH), 7.38 - 
7.28 (5 H, m, 5xArH), 7.26 - 7.20 (1 H, m, ArH), 5.84 (1 H, br. t, 
J = 4.8 Hz, NH), 4.07 – 3.64 (2 H, m, NHCH2CH2Ph), 3.03 ppm 
(2 H, t, J = 6.9 Hz, NHCH2CH2Ph); 
13C {1H} NMR (125 MHz, 
CDCl3): δC = 170.7 (C=O), 138.8 (ArC), 135.7 (ArC), 135.6 
(ArC), 133.3 (ArC), 131.7 (ArC), 130.7 (ArC), 130.5 (ArC), 
128.8 (ArC), 128.7 (ArC), 128.6 (ArC), 128.1 (ArC), 128.1 
(ArC), 126.6 (ArC), 126.5 (ArC), 125.4 (ArC), 119.3 (ArC), 41.4 
(NHCH2CH2Ph), 35.1 (NHCH2CH2Ph) ppm; HRMS (ESI+) m/z 
calcd for C19H16BrNONa [M+Na
+]: 376.0307, found: 376.0294. 
4.1.3. 2-Iodo-N-phenethyl-1-naphthamide (3g) 
Compound 3g was prepared according to the method of 
Glorius et al.15 [RhCp*Cl2]2 (9.3 mg, 0.0014 mmol, 1 mol%), 
AgSbF6 (20.4 mg, 0.058 mmol, 4 mol%), PivOH (165 mg, 1.598 
mmol), 1,2-DCE (7.3 mL), N-phenethyl-1-naphthamide 3d (400 
mg, 1.453 mmol) and NIS (0.360 g, 1.598 mmol). The reaction 
mixture was heated at 60 oC for 16 h. The crude product was 
purified by flash column chromatography (70:30 Pet. 
Ether:EtOAc) to afford the title compound as a yellow solid (199 
 5 
mg, 34%); 3g: Rf  (60:40 Pet. Ether:EtOAc) 0.4; m.p. 138-140 
ºC; IR (film, cm-1): νmax = 3297, 1632 (C=O), 1538, 532; 1H 
NMR (300 MHz, CDCl3): δH = 8.24 (1 H, dd, J=7.3, 1.1 Hz, 
ArH), 7.89 - 7.80 (2 H, m, 2xArH), 7.56 - 7.50 (1 H, m, ArH), 
7.47 - 7.39 (1 H, m, ArH), 7.36 - 7.20 (5 H, m, 5xArH), 7.15 (1 
H, t, J=7.7 Hz, ArH), 5.94 (1 H, br. t, J=5.2 Hz, NH), 3.83 (2 H, 
br. m, NHCH2CH2Ph), 3.03 (2 H, t, J=7.1 Hz, NHCH2CH2Ph) 
ppm; 13C {1H} NMR (100 MHz, CDCl3): δC = 169.8 (C=O), 
141.9 (ArC), 139.7 (ArC), 138.8 (ArC), 137.7 (ArC), 137.4 
(ArC), 135.3 (ArC), 131.3 (ArC), 130.5 (ArC), 129.7 (ArC), 
128.8 (ArC), 128.7 (ArC), 128.3 (ArC), 127.1 (ArC), 126.6 
(ArC), 125.2 (ArC), 92.0 (ArC-I), 41.6 (NHCH2CH2Ph), 35.0 
(NHCH2CH2Ph) ppm; HRMS (ESI+) m/z calcd for 
C19H16INONa [M+Na
+]: 424.0169, found: 424.0155. 
4.2. General procedure for cyclodehydration of amides 3a-g 
to 1-aryl-3,4-dihydroisoquinolines 4a-g. 
The cyclodehydration of amides 3a-g was performed 
according to the method of Movassaghi et al.14b The experimental 
data for 1-(2-chlorophenyl)-3,4-dihydroisoquinoline 4a,26a 1-(2-
bromophenyl)-3,4-dihydroisoquinoline 4b,26b and 1-(2-
bromophenyl)-3,4-dihydroisoquinoline 4c26c were in accordance 
with the literature. 
4.2.1. 1-(Naphthalen-1-yl)-3,4-dihydroisoquinoline (4d) 
General procedure for cyclodehydration of amides was 
followed. Amide 3d (1.000 g, 3.63 mmol), 
trifluoromethanesulfonic anhydride (0.69 mL, 4.00 mmol), 2-
chloropyridine (0.42 mL, 4.36 mmol) in dichloromethane (18 
mL). The reaction mixture was refluxed for 2 h. The crude 
product was purified by flash column chromatography (70:30:1 
Pentane:EtOAc:Et3N) to afford the title compound as a white 
solid (0.752 g, 80%); Rf (70:30 Pet. Ether:EtOAc ) 0.3; 4d: m.p. 
135-136 ºC; IR (film, cm-1): νmax = 1613 (C=O), 759; 1H NMR 
(400 MHz, CDCl3): δH = 7.97 - 7.87 (2 H, m, 2xArH), 7.73 (1 H, 
dq, J=8.4, 0.9 Hz, ArH), 7.58 – 7.52 (2 H, m, 2xArH), 7.47 (1 H, 
ddd, J=8.2, 6.8, 1.3 Hz, ArH), 7.37 (2 H, tdd, J = 7.3, 4.7, 1.4 Hz, 
2xArH), 7.31 (1 H, dd, J = 7.5, 1.3 Hz, ArH), 7.09 (1 H, td, 
J=7.5, 1.4 Hz, ArH), 6.87 (1 H, dd, J=7.7, 1.3 Hz, ArH), 4.06 (2 
H, br. m., J = 5.2 Hz, NCH2CH2Ar), 2.98 ppm (2 H, t, J = 7.5 Hz, 
NCH2CH2Ar); 
13C {1H} NMR (100 MHz, CDCl3): δC = 167.7 
(C=N), 137.5 (ArC), 137.2 (ArC), 133.8 (ArC), 131.7 (ArC), 
131.0 (ArC), 130.3 (ArC), 129.0 (ArC), 128.4 (ArC), 127.9 
(ArC), 127.5 (ArC), 127.1 (ArC), 126.7 (ArC), 126.3 (ArC), 
126.0 (ArC), 125.8 (ArC), 125.4 (ArC), 48.0 (NCH2CH2Ar), 26.3 
(NCH2CH2Ar) ppm; HRMS (ESI+) m/z calcd for C19H16N 
[M+H+]: 258.1277, found: 258.1268. 
4.2.2. 1-(2-Chloronaphthalen-1-yl)-3,4-dihydroisoquinoline 
(4e) 
General procedure for cyclodehydration of amides was 
followed: amide 3e (440 mg, 1.42 mmol), 
trifluoromethanesulfonic anhydride (0.22 mL, 1.56 mmol), 2-
chloropyridine (0.16 mL, 1.70 mmol) in dichloromethane (10 
mL). The reaction mixture was refluxed for 16 h. The crude 
product was purified by flash column chromatography (70:30:1 
Pentane:EtOAc:Et3N) to afford the title compound as a yellow 
solid (363 mg, 88%); 4e: Rf (70:30 Pet. Ether:EtOAc ) 0.3; m.p. 
112-114ºC; IR (film, cm-1): νmax = 2941, 1618 (C=N), 810, 739; 
1H NMR (400 MHz, CDCl3): δH  = 7.95 (1 H, dd, J = 8.1, 1.4 Hz, 
ArH), 7.85 (1 H, dd, J = 8.2, 1.3 Hz, ArH), 7.57 (1 H, t, J = 7.6 
Hz, ArH), 7.51 (2 H, td, dd, J = 7.3, 1.3 Hz, 2xArH), 7.39 (1 H, t, 
J = 7.8 Hz, ArH), 7.34 (1 H, td, J = 7.4, 1.3 Hz, ArH), 7.27 (1 H, 
d, J = 7.4 Hz, ArH), 7.08 (1 H, td, J=7.6, 1.3 Hz, ArH), 6.73 (1 
H, d, J=7.7 Hz, ArH), 4.07 (1 H, ddd, J=14.9, 8.3, 6.3 Hz, 
NCHAHBCH2Ar), 3.96 (1 H, ddd, J = 15.6, 9.5, 6.1 Hz, 
NCHAHBCH2Ar), 3.07–2.88 (2 H, m, NCH2CH2Ar) ppm; 13C 
{1H} NMR (100 MHz, CDCl3): δC  = 169.2 (C=N), 136.9 (ArC), 
136.6 (ArC), 135.9 (ArC), 131.6 (ArC), 130.9 (ArC), 130.6 
(ArC), 129.8 (ArC), 129.8 (ArC), 129.2 (ArC), 129.1 (ArC), 
128.2 (ArC), 127.4 (ArC), 127.4 (ArC), 126.8 (ArC), 126.0 
(ArC), 125.9 (ArC), 48.0 (NCH2CH2Ar), 25.6 (NCH2CH2Ar) 
ppm; HRMS (ESI+) m/z calcd forC19H15NCl [M+H
+]: 292.0888, 
found: 292.0882 
4.2.3. 1-(2-Bromonaphthalen-1-yl)-3,4-dihydroisoquinoline 
(4f) 
General procedure for cyclodehydration of amides was 
followed: amide 3f (0.195 g, 0.56 mmol), 
trifluoromethanesulfonic anhydride (0.13 mL, 0.62 mmol), 2-
chloropyridine (78 µL, 0.68 mmol) in dichloromethane (3 mL). 
The reaction mixture was stirred at 45 ºC for 16 h. The crude 
product was purified by flash column chromatography (70:30:1 
Pentane:EtOAc:Et3N) to afford the title compound as a yellow oil 
(0.166 g, 90%); 4f: Rf (70:30 Pet. Ether:EtOAc ) 0.3; IR (film, 
cm-1): νmax = 2928, 1298, 821, 764; 1H NMR (500 MHz, CDCl3): 
δH = 7.94 (1 H, dd, J=7.0, 2.5 Hz, ArH), 7.89 (1 H, dd, J=8.2, 1.3 
Hz, ArH), 7.80 (1 H, dd, J=7.4, 1.2 Hz, ArH), 7.58 - 7.50 (2 H, 
m, 2xArH), 7.35 (1 H, td, J=7.4, 1.3 Hz, ArH), 7.28 (2 H, m, 
2xArH), 7.09 (1 H, td, J= 7.6, 1.3 Hz, ArH), 6.81 (1 H, dd, J = 
7.6, 1.2 Hz, ArH), 4.07 (2 H, m, NCHAHBCH2Ar), 2.99 (2 H, m, 
NCH2CH2Ar) ppm; 
13C {1H} NMR (125 MHz, CDCl3): δC = 
168.5(C=N), 137.3 (ArC), 136.7 (ArC), 135.8 (ArC), 133.1 
(ArC), 131.7 (ArC), 130.4 (ArC), 130.3 (ArC), 129.9 (ArC), 
129.8 (ArC), 128.7 (ArC), 127.5 (ArC), 127.2 (ArC), 126.6 
(ArC), 126.1 (ArC), 125.6 (ArC), 119.7 (ArC-Br), 47.8 
(NCH2CH2Ar), 25.3 (NCH2CH2Ar) ppm; HRMS (ESI+) m/z 
calcd forC19H14NBrNa [M+Na
+]: 358.0202, found: 358.0206. 
4.2.4. 1-(2-Iodonaphthalen-1-yl)-3,4-dihydroisoquinoline (4g) 
General procedure for cyclodehydration of amides was 
followed: amide 3g (0.100 g, 0.25 mmol), 
trifluoromethanesulfonic anhydride (47 µL, 0.27 mmol), 2-
chloropyridine (29 µL, 0.30 mmol) in dichloromethane (1.5 mL). 
The reaction mixture was stirred at 45 ºC for 16 h. The crude was 
purified by flash column chromatography (70:30:1 
Pentane:EtOAc:Et3N) to afford the title compound as a yellow oil 
(0.062 g, 65%); 4g: Rf (70:30 Pet. Ether:EtOAc ) 0.35; IR (film, 
cm-1): νmax = 2934, 818, 740, 713; 1H NMR (400 MHz, CDCl3): 
δH = 8.20 (1 H, dd, J= 7.4, 1.3 Hz, ArH), 7.96 - 7.85 (2 H, m, 
2xArH), 7.54 - 7.43 (2 H, m, 2xArH), 7.36 (1 H, dd, J= 8.2, 7.0 
Hz, ArH), 7.29 – 7.22 (1 H, m, ArH), 7.19 - 7.11 (2 H, m, 
2xArH), 6.87 (1 H, d, J=7.7 Hz, ArH), 4.17 (1 H, dt, J=15.6, 6.2 
Hz, NCHAHBCH2Ar), 4.01 (1 H, ddd, J = 15.7, 11.2, 6.9 Hz, 
NCHAHBCH2Ar), 3.11 - 2.92 (2 H, m, NCHAHBCH2Ar) ppm; 
13C 
{1H} NMR (100 MHz, CDCl3): δC = 167.8 (C=N), 141.8 (ArC), 
138.9 (ArC), 137.1 (ArC), 135.9 (ArC), 133.1 (ArC), 132.6 
(ArC), 130.8 (ArC), 130.5 (ArC), 130.2 (ArC), 129.9 (ArC), 
128.3 (ArC), 127.5 (ArC), 126.9 (ArC), 126.9 (ArC), 125.5 
(ArC), 92.4 (ArC-I), 48.0 (NCH2CH2Ar), 25.6 (NCH2CH2Ar) 
ppm; HRMS (ESI+) m/z calcd for C19H15NI [M+H
+]: 384.0244, 
found: 384.0243. 
4.3. 1-(3,4-Dihydroisoquinolin-1-yl)naphthalen-2-yl 
trifluoromethanesulfonate (4h) 
Compound 4h was prepared from 2-naphthol (1.33 g, 9.10 mmol) 
and 3,4-dihydroisoquinoline (1.19 g, 9.10 mmol) according to the 
synthetic route reported by Li et al.9 The crude product was 
purified by flash column chromatography to afford the title 
compound as a clear oil (3.13 g, 85% overall yield); Rf (70:30:1 
Pet. Ether:EtOAc:Et3N) 0.6; IR (film, cm
-1): νmax = 1618 (C=N), 
 6 
1420, 1200, 1140; 1H NMR (500 MHz, CDCl3): δH = 8.00 (1 H, 
d, J=9.0 Hz, ArH), 7.95 (1 H, d, J = 8.1 Hz, ArH), 7.70 (1 H, dd, 
J=8.4, 1.0 Hz, ArH), 7.56 (1 H, ddd, J = 8.2, 6.8, 1.2 Hz, ArH), 
7.51 - 7.46 (2 H, m, 2xArH), 7.38 (1 H, td, J=7.5, 1.3 Hz, ArH), 
7.31 (1 H, dd, J=7.5, 1.2 Hz, ArH), 7.09 (1 H, td, J=7.5, 1.2 Hz, 
ArH), 6.75 (1 H, dd, J=7.6, 1.2 Hz, ArH), 4.19 - 4.05 (2 H, m, 
NCHAHBCH2Ar), 3.09 - 2.93 (2 H, m, NCH2CH2Ar) ppm; 
13C 
{1H} NMR (125 MHz, CDCl3): δC =162.7 (C=N), 144.6 (ArC), 
137.3(ArC), 132.6 (ArC), 131.6 (ArC), 131.1 (ArC), 129.7 
(ArC), 129.3 (ArC), 128.4 (ArC), 128.0 (ArC), 127.8 (ArC), 
127.3 (ArC), 127.3 (ArC), 127.1 (ArC), 126.3 (ArC), 119.8 
(ArC), 119.4 (ArC), 117.3 (ArCSO2CF3), 48.1 (NCH2CH2Ar), 
25.7 (NCH2CH2Ar); HRMS (ESI+) m/z calcd for 
C20H14F3NNaO3S [M+Na
+]: 428.0539, found: 428.0544. HPLC: 
Chiralpak® AD-H, n-Hex:IPA = 80:20, T = 25 oC; flow = 1 
mL/min, λ = 254 nm, tR,A = 4.8 min, tR,B = 8.2 min. 
4.4. (1-(3,4-Dihydroisoquinolin-1-yl)naphthalen-2-
yl)diphenylphosphine oxide (4i) 
Compound 4i was prepared according to the method of Mikami 
et al.17 Dimethylsulfoxide (8 mL) and diisopropylethylamine 
(1.29 mL, 7.4 mmol) were added to a mixture of 1-aryl-3,4-
dihydroisoquinoline 4h (600 mg, 1.48 mmol), diphenylphosphine 
oxide (617 mg, 2.96 mmol), palladium diacetate (33 mg, 0.15 
mmol, 10 mol%), and 1,3-bis(diphenylphosphino)propane (dppp; 
94 mg, 0.22 mmol, 15 mol%), and the mixture was heated with 
stirring at 100 ºC for 22 h. After cooling to room temperature, the 
reaction mixture was diluted with EtOAc, washed with water, 
dried over MgSO4, and concentrated again under reduced 
pressure. The crude product was purified by flash column 
chromatography (EtOAc:MeOH 95:5) to afford the title 
compound as a yellow solid (0.508 g, 75%); 4i: Rf (95:5 
EtOAc:MeOH ) 0.6; m.p. 97-98 ºC; IR (film, cm-1): νmax = 1629 
(C=N), 1196; 1H NMR (400 MHz, CDCl3): δH = 7.88 (2 H, dd, 
J=8.6, 1.3 Hz, 2xArH), 7.71 (1 H, d, J=8.8 Hz, ArH), 7.65 - 7.50 
(6 H, m, 6xArH), 7.50 - 7.31 (7 H, m, 7xArH), 7.23 (1 H, td, 
J=7.3, 1.0 Hz, ArH), 7.17 (1 H, dd, J=7.3, 0.5 Hz, ArH), 6.88 (1 
H, td, J=7.4, 1.3 Hz, ArH), 6.59 (1 H, d, J=7.1 Hz,ArH), 3.81 (2 
H, m, NCH2CH2Ar), 3.01 (1 H, dt, J=16.0, 8.0 Hz, 
NCH2CHXCHYAr), 2.81 ppm (1 H, dt, J=16.0, 7.0 Hz, 
NCH2CHXCHYAr); 
13C {1H} NMR (100 MHz, CDCl3): δC = 
166.3 (ArC=N, d, J(13C,31P) = 4.0 Hz), 143.3 (ArC, d, J(13C,31P)) 
= 8.0 Hz), 136.8, 134.6, 134.6, 134.2, 133.5, 132.2, 132.1, 132.0, 
132.0, 131.9, 131.4, 131.4, 130.8, 130.4, 128.6, 128.2, 128.2, 
128.1, 128.1, 128.0, 128.0, 127.9, 127.7, 127.5, 127.3, 127.2, 
127.1, 126.7, 126.3, 47.5 (NCH2CH2Ar), 25.4 (NCH2CH2Ar) 
ppm; 31P {1H} NMR (162 MHz, CDCl3): δP = 29.6 ppm. HRMS 
(ESI+) m/z calcd for C31H24ONNaP [M+Na
+]: 480.1488, found: 
480.1475. HPLC: (R,R)-Whelk-O1, n-Hex:IPA = 60:40, T = 50 
oC; flow = 1 mL/min, λ = 254 nm, tR,A = 6.8 min, tR,B = 10.2 min. 
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